Patient Education Blog

Posts Tagged ‘WARFASA’

Aspirin Can Prevent Recurrent DVT and PE

| Aspirin, Therapy | Comments Off on Aspirin Can Prevent Recurrent DVT and PE

Stephan Moll, MD writes… For patients stopping blood thinning therapy (anticoagulation) whose deep vein thrombosis (DVT) or pulmonary embolism (PE) was considered unprovoked (i.e. out of the blue and with no obvious triggering, transient cause, such as surgery, hormone use, immobility), aspirin is beneficial in some patients in preventing further clots.  A new publication in the journal Circulation re-confirms findings from two previous studies, showing that aspirin reduces the risk of recurrent DVT/PE by more than a third without significantly increasing the risk of bleeding [ref 1,2,3]. Read the rest of this entry »

Does Aspirin Prevent Recurrence of DVT and PE? – Well, it’s Not Clear

| Therapy | Comments Off on Does Aspirin Prevent Recurrence of DVT and PE? – Well, it’s Not Clear

 Stephan Moll, MD writes… An important study (ASPIRE trial), relevant for patients with a history of DVT or PE, was published this week (Nov 22nd, 2012) in the New England Journal of Medicine [ref 1] . It showed that aspirin is not effective in preventing further DVT or PE in patients who have had a previous unprovoked (= idiopathic) DVT or PE and who have completed standard length (often considered to be 3-6 months) of blood thinner (warfarin) therapy.  However, aspirin still had some benefit – it decreased the occurence of “vascular events” (i.e. a conglomerate of heart attacks, strokes, and DVT and PE when all were grouped together).  Aspirin did not lead to an increase in risk of major bleeding. Read the rest of this entry »